Heart Test Labs Files 8-K on Operations and Financials
Ticker: HSCSW · Form: 8-K · Filed: Mar 14, 2024 · CIK: 1468492
| Field | Detail |
|---|---|
| Company | Heart Test Laboratories, Inc. (HSCSW) |
| Form Type | 8-K |
| Filed Date | Mar 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, reporting
TL;DR
Heart Test Labs dropped an 8-K detailing its financials and operations - check it for the latest.
AI Summary
Heart Test Laboratories, Inc. filed an 8-K on March 14, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing pertains to the company's ongoing business operations and financial reporting requirements.
Why It Matters
This filing provides crucial updates on Heart Test Laboratories' financial health and operational performance, which are essential for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Heart Test Laboratories, Inc. (company) — Registrant
- March 14, 2024 (date) — Date of earliest event reported
- Texas (location) — State of Incorporation
- 550 Reserve Street, Suite 360 (address) — Principal Executive Office Address
- Southlake, Texas (address) — City and State of Principal Executive Office
- 76092 (zip_code) — Zip Code of Principal Executive Office
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on March 14, 2024.
What is the principal executive office address of Heart Test Laboratories, Inc.?
The principal executive office is located at 550 Reserve Street, Suite 360, Southlake, Texas 76092.
In which state is Heart Test Laboratories, Inc. incorporated?
Heart Test Laboratories, Inc. is incorporated in Texas.
What is the Commission File Number for Heart Test Laboratories, Inc.?
The Commission File Number is 001-41422.
Filing Stats: 532 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-03-14 16:15:13
Filing Documents
- ea0201847-8k_hearttest.htm (8-K) — 27KB
- ea020184701ex99-1_hearttest.htm (EX-99.1) — 25KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001213900-24-022613.txt ( ) — 278KB
- hscs-20240314.xsd (EX-101.SCH) — 3KB
- hscs-20240314_def.xml (EX-101.DEF) — 26KB
- hscs-20240314_lab.xml (EX-101.LAB) — 36KB
- hscs-20240314_pre.xml (EX-101.PRE) — 25KB
- ea0201847-8k_hearttest_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On March 14, 2024, Heart Test Laboratories, Inc. (the "Company") issued a press release providing information regarding the Company's financial and operating results for the quarter ended January 31, 2024, and other business updates. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information contained in Item 2.02 of this report and Exhibit 99.1 to this report shall not be deemed to be "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be incorporated by reference into any filings made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated March 14, 2024 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEART TEST LABORATORIES, INC. Date: March 14, 2024 By: /s/ Andrew Simpson Name: Title: Andrew Simpson President, Chief Executive Officer and Chairman of the Board of Directors 2